Advances in Chronic Kidney Disease
Volume 17, Issue 1 , Pages 59-71 , January 2010

The Treatment of HIV-Associated Nephropathy

  • Robert C. Kalayjian

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dr Robert Kalayjian, Division of Infectious Diseases, 2500 MetroHealth Drive, Cleveland, OH 44102-1998.

References 

  1. Hammer SM, Eron JJ, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555–570
  2. Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis. 1996;28:202–208
  3. Szczech LA, Edwards LJ, Sanders LL, et al. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol. 2002;57:336–341
  4. Lucas GM, Eustace JA, Sozio S, et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS. 2004;18:541–546
  5. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145–1152
  6. Smith MC, Austen JL, Carey JT, et al. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med. 1996;101:41–48
  7. Laradi A, Mallet A, Beaufils H, et al. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol. 1998;9:2327–2335
  8. Eustace JA, Nuermberger E, Choi M, et al. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int. 2000;58:1253–1260
  9. Wei A, Burns GC, Williams BA, et al. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int. 2003;64:1462–1471
  10. Krawczyk CS, Holmberg SD, Moorman AC, et al. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS. 2004;18:2171–2178
  11. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283–2296
  12. Kalayjian RC, Franceschini N, Gupta SK, et al. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS. 2008;22:481–487
  13. Peters PJ, Moore DM, Mermin J, et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 2008;74:925–929
  14. Reid A, Stohr W, Walker AS, et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008;46:1271–1281
  15. Longenecker CT, Scherzer R, Bacchetti P, et al. HIV viremia and changes in kidney function. AIDS. 2009;23:1089–1096
  16. Beversluis D, Reynolds S, Kityo C, et al: Greater Renal Function Preservation Is Associated with Continuous vs Intermittent ART [Abstract 742]. In: Programs and Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal, Quebec) 2009. Available at: http://www.retroconference.org. Accessed February 22, 2009
  17. Crane HM, Kestenbaum B, Harrington RD, et al. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir. AIDS. 2007;21:1431–1439
  18. Mulenga LB, Kruse G, Lakhi S, et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS. 2008;22:1821–1827
  19. Post FA, Campbell LJ, Hamzah L, et al. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis. 2008;46:1282–1289
  20. Han TM, Naicker S, Ramdial PK, et al. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006;69:2243–2250
  21. Nochy D, Glotz D, Dosquet P, et al. Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant. 1993;8:11–19
  22. Connolly JO, Weston CE, Hendry BM. HIV-associated renal disease in London hospitals. QJM. 1995;88:627–634
  23. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int. 1999;55:1036–1040
  24. Cohen SD, Kimmel PL. Immune complex renal disease and human immunodeficiency virus infection. Semin Nephrol. 2008;28:535–544
  25. Berliner AR, Fine DM, Lucas GM, et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol. 2008;28:478–486
  26. Lucas GM, Lau B, Atta MG, et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: A tale of two races. J Infect Dis. 2008;197:1548–1557
  27. Briggs WA, Tanawattanacharoen S, Choi MJ, et al. Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy. Am J Kidney Dis. 1996;28:618–621
  28. Navarrete JE, Pastan SO. Effect of highly active antiretroviral treatment and prednisone in biopsy-proven HIV-associated nephropathy. J Am Soc Nephrol. 2000;11:A0504
  29. Glesby MJ, Hoover DR, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: A case-control study. J Infect Dis. 2001;184:519–523
  30. Miller KD, Masur H, Jones EC, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med. 2002;137:17–25
  31. Wali RK, Drachenberg CI, Papadimitriou JC, et al. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet. 1998;352:783–784
  32. Dellow E, Unwin R, Miller R, et al. Protease inhibitor therapy for HIV infection: the effect on HIV-associated nephrotic syndrome. Nephrol Dial Transplant. 1999;14:744–747
  33. Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001;344:1979–1984
  34. Betjes MG, Verhagen DW. Stable improvement of renal function after initiation of highly active anti-retroviral therapy in patients with HIV-1-associated nephropathy. Nephrol Dial Transplant. 2002;17:1836–1839
  35. Mocroft A, Wyatt C, Szczech L, et al. Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS. 2009;23:71–82
  36. Gupta SK, Smurzynski M, Franceschini N, et al. The effects of HIV-1 viral suppression and non-viral factors on quantitative proteinuria in the HAART era. Antivir Ther. 2009;14:543–549
  37. Gupta SK, Parker RA, Robbins GK, et al. The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: Results from a randomized trial. Nephrol Dial Transplant. 2005;20:2237–2242
  38. Rodriguez RA, Mendelson M, O'Hare AM, et al. Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol. 2003;14:1307–1313
  39. Szczech LA, Kalayjian R, Rodriguez R, et al. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. Kidney Int. 2003;63:2295–2301
  40. Izzedine H, Launay-Vacher V, Deray G. Inadequacy of antiretroviral drugs dosage adjustment in HIV patients receiving dialysis. Kidney Int. 2003;64:2324
  41. Choi AI, Rodriguez RA, Bacchetti P, et al. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007;45:1633–1639
  42. Tourret J, Tostivint I, Tezenas Du Montcel S, et al. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis. Clin Infect Dis. 2007;45:779–784
  43. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559–1585
  44. Winston J, Deray G, Hawkins T, et al. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47:1449–1457
  45. Cohen AH, Sun NC, Shapshak P, et al. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol. 1989;2:125–128

 Supported by NIH grants AI36219 and AI25879.

PII: S1548-5595(09)00171-2

doi: 10.1053/j.ackd.2009.08.013

Advances in Chronic Kidney Disease
Volume 17, Issue 1 , Pages 59-71 , January 2010

Article Tools